FDA Approves FLAVALTA (LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE) — New Treatment Available

WHY IT MATTERS

This approval makes a new numbing and bleeding-control medication available to patients who need it, though the specific rare disease indication requires clarification from your doctor or the full prescribing information.

The FDA has approved a new drug called FLAVALTA, which contains lidocaine and epinephrine. Lidocaine is a numbing medication, and epinephrine helps control bleeding. This approval means the drug is now available for patients to use, though the specific medical condition it treats is not detailed in this announcement.

Drug: FLAVALTA Generic name: LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE Sponsor: DEPROCO Application: NDA216564 (ORIG) FDA approval date: 2026-03-19 Source: FDA Drugs@FDA database

ASK YOUR DOCTOR

Ask your doctor at your next appointment whether FLAVALTA might be appropriate for your condition, or contact the manufacturer DEPROCO directly for more information about eligibility and access.